Zobrazeno 1 - 10
of 274
pro vyhledávání: '"tmp-smx"'
Autor:
Vikram B. Vikhe, Ahsan A. Faruqi
Publikováno v:
Medical Journal of Dr. D.Y. Patil Vidyapeeth, Vol 17, Iss 4, Pp 893-896 (2024)
We present a case of a young male from a low socioeconomic background who presented with mucosal ulceration, hematemesis episodes, and pancytopenia following treatment with trimethoprim-sulfamethoxazole (TMP-SMX) for a urinary tract infection. On exa
Externí odkaz:
https://doaj.org/article/df25efc972064c2ab464771645817a1b
Publikováno v:
Infection and Drug Resistance, Vol Volume 17, Pp 1523-1528 (2024)
Rui Juan Song, Guang Lin Zhang Department of Infectious Diseases, Anhui Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hefei, People’s Republic of ChinaCorrespondence: Guang Lin Zhang, Department of Infectious Diseases,
Externí odkaz:
https://doaj.org/article/568bccf12b614f57b4aba3fe9a89add3
Autor:
Léo Sauvat, Laure Denis, Céline Nourrisson, Philippe Poirier, Marc Ruivard, Guillaume Le Guenno
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundPneumocystis jirovecii pneumonia (PCP) has a significant mortality rate for non-HIV immunocompromised patients. Prevention is primarily based on combined trimethoprim and sulfamethoxazole (TMP-SMX) but guidelines on pneumocystosis prophylax
Externí odkaz:
https://doaj.org/article/5735b2b827364636ab5a38a13ffef692
Autor:
Masoud Dadashi, Bahareh Hajikhani, Nooshin Nazarinejad, Negin Noorisepehr, Shahrooz Yazdani, Ali Hashemi, Zahra Hashemizadeh, Mehdi Goudarzi, Sameni Fatemeh
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 34, Iss , Pp 253-267 (2023)
ABSTRACT: Objectives: Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen, causes infection in patients undergoing immunosuppressive therapy, mechanical ventilation, or catheters and in long-term hospitalized patients. Due to its
Externí odkaz:
https://doaj.org/article/265440f06c23406dadccc9bb416a6de8
Autor:
Hala Alghoraibi, Aisha Asidan, Raneem Aljawaied, Raghad Almukhayzim, Aljoharah Alsaydan, Elaf Alamer, Waleed Baharoon, Emad Masuadi, Abeer Al Shukairi, Laila Layqah, Salim Baharoon
Publikováno v:
Journal of Epidemiology and Global Health, Vol 13, Iss 2, Pp 200-211 (2023)
Abstract Background Recurrent urinary tract infection (UTI) occurs in sizable percentages of patients after a single episode and is a frequent cause of primary healthcare visits and hospital admissions, accounting for up to one quarter of emergency d
Externí odkaz:
https://doaj.org/article/33950c4e534047ed8c4c4cbf9a1b3fa1
Autor:
Liu Chia-Wei, Jan-Fang Cheng, Kwong-Chung Tung, Yu-Kai Hong, Jyun-Hong Lin, Yu-Hui Lin, Che-An Tsai, Shih-Ping Lin, Yung-Chun Chen, Zhi-Yuan Shi, Yao-Ting Huang, Po-Yu Liu
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 55, Iss 6, Pp 1195-1202 (2022)
Objective: Shewanella algae is a zoonotic marine bacterium that causes a variety of infections in immunocompromised patients or those who have been exposed to seawater. The development of trimethoprim/sulfamethoxazole (TMP/SMX) resistance in S. algae
Externí odkaz:
https://doaj.org/article/a054d974ab424d8c91e169d9416299de
Autor:
Mazin Barry, Shahad AlShehri, Ahlam alguhani, Mohammad Barry, Ali Alhijji, Khalifa Binkhamis, Fahad Al-Majid, Fatimah S. Al-Shahrani, Taim Muayqil
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Disseminated nocardiosis still causes significant morbidity and mortality and is often caused by Nocardia asteroides, N. basiliensis, and N. farcinica and are often treated with trimethoprim–sulfamethoxazole (TMP–SMX). Nocardi
Externí odkaz:
https://doaj.org/article/5fd57bb20ab840aaa4615aed095e2780
Publikováno v:
IDCases, Vol 34, Iss , Pp e01917- (2023)
Trimethoprim-sulfamethoxazole (TMP-SMX), also referred to as co-trimazole, is a common antibiotic used to treat a wide range of infections ranging from simple skin and soft tissue infections to opportunistic infections such as Pneumocystis jirovecii.
Externí odkaz:
https://doaj.org/article/83b2c068badd4c8189a25dbbd01b99ec
Publikováno v:
Clinical Case Reports, Vol 10, Iss 10, Pp n/a-n/a (2022)
Abstract We present the case of a 55‐year‐old male patient who developed hyperkalemia after using Cotrimoxazole (TMP‐SMX). There was a marked increase in potassium levels from 3.3 mEq/L on Day 5 when cotrimoxazole was started to 6.2 mEq/L on Da
Externí odkaz:
https://doaj.org/article/16002ba2e73348218e80e14e8e141f8c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.